Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Probiotics as medical therapies

Mark A. Miller
CMAJ November 27, 2001 165 (11) 1470;
Mark A. Miller
Chief Department of Microbiology Sir Mortimer B. Davis – Jewish General Hospital Montreal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

I am disappointed that the editors of CMAJ published a misleading and biased research letter on the “underuse of probiotics.”1 I believe that there is some biological plausibility to the potential effectiveness of probiotics as therapies for certain medical conditions.2 However, each of these agents must be tested and assessed in proper trials. In fact, I recently completed a study of the effectiveness of Lactobacillus rhamnosus GG in preventing Clostridium difficile-associated diarrhea (CDAD).

Lindsey Edmunds is incorrect in stating that antibiotic-related diarrhea can sometimes “cause pseudomembranous colitis.” Pseudomembranous colitis (or CDAD) is not caused by diarrhea. It is one type of antibiotic-associated diarrhea, accounting for approximately 40% of diarrhea in patients in hospital who are receiving antibiotics.

More importantly, her assertion that “probiotics … beneficially affect humans by altering their intestinal microbial balance” is unsubstantiated, yet she states it as fact. The mechanisms by which probiotics exert their effects are largely unknown.3 Describing the benefits of probiotics as if they were a single agent is similar to lumping all antihypertensive drugs together as a single drug type and saying that they are beneficial. In fact, even closely related probiotics, such as similar Lactobacillus species, have displayed varying effects when tested in humans.4 In addition, some “natural” probiotic products have been shown to contain only dead bacteria (owing to improper manufacturing or storage) or to have bacterial contents other than those stated on the label.2,5 An authoritative review of probiotics recognized that the “definition of the pharmacodynamic profiles and viability of organisms in many commercially produced probiotic preparations are lacking.”2

I applaud Edmunds' use of a questionnaire to survey physicians' attitudes concerning probiotics. However, the author's assertion that all probiotics are beneficial but underutilized is a biased notion that is inappropriate as a starting point for a study of this type. The research letter should have been entitled “Attitudes of family physicians about probiotic use,” to avoid the assertion in the author's own title that underuse is bad. Such assertions only add to the myths surrounding such therapies, making it more difficult to test and develop the individual probiotics that would truly benefit humans.

References

  1. 1.↵
    Edmunds L. The underuse of probiotics by family physicians. CMAJ 2001;164(11):1577.
    OpenUrlFREE Full Text
  2. 2.↵
    Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001; 32:1567-76.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 101:229-38.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Salminen S, Arvilommi H. Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis 2001;32:1577-78.
    OpenUrlFREE Full Text
  5. 5.↵
    Temmerman R, Pot B, Swings J. Identification, antibiotic resistance and gastrointestinal tract survival of isolates from probiotic products. 101st General Meeting of the American Society of Microbiology; 2001 May 20–24; Orlando (FL). Abstr. no. C-1289.
PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 11
27 Nov 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Probiotics as medical therapies
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Probiotics as medical therapies
Mark A. Miller
CMAJ Nov 2001, 165 (11) 1470;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Probiotics as medical therapies
Mark A. Miller
CMAJ Nov 2001, 165 (11) 1470;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Virtual care and emergency department use
  • The denial of racism is racism itself
  • An expanded role for blood donor emerging pathogens surveillance
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire